CLARICE HART: Open Payments
NPI 1073190542 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,746 in 179 payments from 28 companies in 2025. Trend: 2023 $3,616 · 2024 $4,458 · 2025 $3,746
Food & beverage: $3,746
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $575 |
| AstraZeneca Pharmaceuticals LP | 9 | $343 |
| Novo Nordisk Inc | 14 | $304 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $269 |
| Exact Sciences Corporation | 9 | $264 |
| UCB, Inc. | 9 | $231 |
| Lilly USA, LLC | 14 | $206 |
| Viatris Specialty LLC | 6 | $175 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $169 |
| Axsome Therapeutics, Inc. | 3 | $166 |
Products named: Ozempic, JARDIANCE, Bimzelx, The Cologuard Plus Collection Kit, VRAYLAR, SAPHNELO, YUPELRI, SKYRIZI.
Industry payments across NY — which companies pay providers there.
